Raymond James analyst David Novak raised the price target on Zymeworks (NYSE: ZYME) to $74.00 (from $60.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE